NewsRx

Search our medical news database

Lyme Disease (Diagnosis)

Dot Blot Test Detects Infection in Vaccine Recipients

Published in TB and Outbreaks Week, January 18th, 2000

The commercially available dot blot test can defect Borrelia burgdorferi infection in vaccine recipients.

Serology is used routinely as an aid for diagnosing Lyme borreliosis, despite concerns about the sensitivity and specificity of many tests. The commercial release of the recombinant OspA vaccine for preventing Lyme disease will present additional problems for laboratory-based testing, noted Paul T. Fawcett and colleagues.

Reported efficacy of the vaccine, especially during the first year, indicates that a substantial number of vaccine recipients may become infected with Borrelia burgdorferi. The conventional enzyme-linked...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook